You are now leaving the Voltaren.co.zasite and moving to an external website independently operated and not managed by GSK.
GSK assumes no responsibility for the site.
If you wish to leave the site, click 'continue'.
*We do not supply our products directly to consumers. By selecting the Buy Now button on this page, you will be re-directed to a list of retailers’ websites for purchase. Kindly note that purchase will be subject to stock availability.
Promotion of Access to Information Act (PAIA)
The PAIA manual is prepared in accordance with section 51 of the Promotion of Access to Information Act (PAIA) No. 2 of 2000 (as amended) and the Protection of Personal Information Act, 2013. The purpose of PAIA is to promote the right of access to information, to foster a culture of transparency and accountability within the Company by giving the right to information that is required for the exercise or protection of any right and to actively promote a society in which the people of South Africa have effective access to information to enable them to exercise and protect their rights.
Please see the PAIA manual.
Applicant: Haleon South Africa (Pty) Ltd. 11 Hawkins Avenue, Epping Industria 1, Cape Town, 7450. Reg. No: 2014/173930/07. Haleon Hotline on 0800 007 018, mystory.za@haleon.com.
Members of: Marketing Code Authority: info@marketingcode.co.za, Tel. No. +27 63 044 5200. South African Health Products Regulatory Authority Tel. No. +27 12 501 0300 Email: enquiries@sahpra.org.za
©2024 Haleon Group of Companies or its licensor.
This website is intended for South Africa residents only. Trade marks are registered to Haleon group of Companies.
PM-ZA-VOLT-24-00001
PM-ZA-VOLT-24-00002
PM-ZA-VOLT-24-00003
Date of approval of PIL:
Voltaren Emulgel 4 August 2020
Voltaren Emulgel 12hr 30 November 2020